First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Acute Graft Versus Host Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital, Zhejiang University School of Medicine., Hangzhou, Zhejiang, China
Contact: Principal Investigator (Yi Luo, MD)
Study leads
Yi Luo
Principal Investigator
Zhejiang University